Skip to main content
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.590
-0.030 (-1.85%)
Mar 28, 2025, 4:00 PM EDT - Market closed

Aclaris Therapeutics Revenue

In the year 2024, Aclaris Therapeutics had annual revenue of $18.72M, down -40.09%. Aclaris Therapeutics had revenue of $9.21M in the quarter ending December 31, 2024, a decrease of -47.58%.

Revenue (ttm)
$18.72M
Revenue Growth
-40.09%
P/S Ratio
6.69
Revenue / Employee
$292,500
Employees
64
Market Cap
171.59M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202418.72M-12.53M-40.09%
Dec 31, 202331.25M1.50M5.03%
Dec 31, 202229.75M22.99M340.05%
Dec 31, 20216.76M279.00K4.30%
Dec 31, 20206.48M2.26M53.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ACRS News

More News